Principles of Periodontology

Periodontal diseases are among the most common diseases affecting humans. Dental biofilm is a contributor to the etiology of most periodontal diseases. It is also widely accepted that immunological and inflammatory responses to biofilm components are manifested by signs and symptoms of periodontal disease. The outcome of such interaction is modulated by risk factors (modifiers), either inherent (genetic) or acquired (environmental), significantly affecting the initiation and progression of different periodontal disease phenotypes. While definitive genetic determinants responsible for either susceptibility or resistance to periodontal disease have yet to be identified, many factors affecting the pathogenesis have been described, including smoking, diabetes, obesity, medications, and nutrition. Currently, periodontal diseases are classified based upon clinical disease traits using radiographs and clinical examination. Advances in genomics, molecular biology, and personalized medicine may result in new guidelines for unambiguous disease definition and diagnosis in the future. Recent studies have implied relationships between periodontal diseases and systemic conditions. Answering critical questions regarding host‐parasite interactions in periodontal diseases may provide new insight in the pathogenesis of other biomedical disorders. Therapeutic efforts have focused on the microbial nature of the infection, as active treatment centers on biofilm disruption by non‐surgical mechanical debridement with antimicrobial and sometimes anti‐inflammatory adjuncts. The surgical treatment aims at gaining access to periodontal lesions and correcting unfavorable gingival/osseous contours to achieve a periodontal architecture that will provide for more effective oral hygiene and periodontal maintenance. In addition, advances in tissue engineering have provided innovative means to regenerate/repair periodontal defects, based upon principles of guided tissue regeneration and utilization of growth factors/biologic mediators. To maintain periodontal stability, these treatments need to be supplemented with long‐term maintenance (supportive periodontal therapy) programs

Monoaminergic and histaminergic strategies and treatments in brain diseases

The monoaminergic systems are the target of several drugs for the treatment of mood, motor and cognitive disorders as well as neurological conditions. In most cases, advances have occurred through serendipity, except for Parkinson's disease where the pathophysiology led almost immediately to the introduction of dopamine restoring agents. Extensive neuropharmacological studies first showed that the primary target of antipsychotics, antidepressants, and anxiolytic drugs were specific components of the monoaminergic systems. Later, some dramatic side effects associated with older medicines were shown to disappear with new chemical compounds targeting the origin of the therapeutic benefit more specifically. The increased knowledge regarding the function and interaction of the monoaminergic systems in the brain resulting from in vivo neurochemical and neurophysiological studies indicated new monoaminergic targets that could achieve the efficacy of the older medicines with fewer side-effects. Yet, this accumulated knowledge regarding monoamines did not produce valuable strategies for diseases where no monoaminergic drug has been shown to be effective. Here, we emphasize the new therapeutic and monoaminergic-based strategies for the treatment of psychiatric diseases. We will consider three main groups of diseases, based on the evidence of monoamines involvement (schizophrenia, depression, obesity), the identification of monoamines in the diseases processes (Parkinson's disease, addiction) and the prospect of the involvement of monoaminergic mechanisms (epilepsy, Alzheimer's disease, stroke). In most cases, the clinically available monoaminergic drugs induce widespread modifications of amine tone or excitability through neurobiological networks and exemplify the overlap between therapeutic approaches to psychiatric and neurological conditions. More recent developments that have resulted in improved drug specificity and responses will be discussed in this review.peer-reviewe

Documenting contamination in ancient starch laboratories

Ancient starch analysis is an important methodology for researching ancient ecology, plant use, diet, and tool function; particularly in the deep past when other proxies may not survive. Establishing the authenticity of ancient starch is therefore a major concern for researchers. Despite decades of archaeological application, there are currently no empirically-tested procedures for systematically assessing and reducing intra-laboratory contamination. At the Universities of Oxford and Calgary, we have tested laboratory consumables, airborne contaminants, and decontamination techniques (oxidisation, boiling, autoclaving, torching) to establish contamination sources, types and quantities, as well as the most effective methods of destroying them. In our laboratories, we found that (i) contaminant starches represent a restricted range of types, (ii) many commonly used consumables including non-powdered gloves and Calgon are starch-rich, (iii) passive slide traps often used to test for airborne contaminants generate unreliable proxies and unacceptably low statistical confidence, and (iv) decontamination procedures using weak acids and bleach are largely ineffective. This collaborative study has allowed us to identify and reduce the risk of contamination and to develop better internal authenticity criteria for future ancient starch studies conducted in our laboratories

Happy but unhealthy: The relationship between social ties and health in an emerging network

Social connections are essential to health and wellbeing. However, when pursing social acceptance, people may sometimes engage in behavior that is detrimental to their health. Using a multi-time point design, we examined whether the structure of an emerging network of students in an academic summer school program correlated with their physical health and mental wellbeing. Participants who were more central in the network typically experienced greater symptoms of illness (e.g., cold/flu symptoms), engaged in riskier health behaviors (e.g., binge drinking), and had higher physiological reactivity to a stressor. At the same time, they were happier, felt more efficacious, and perceived less stress in response to a strenuous math task. These outcomes suggest that social ties in an emerging network are associated with better mental wellbeing but also with poorer physical health and health behaviors.status: publishe